SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Primedex Health Systems, Inc. (Nasdaq BB: PMDX)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: brian who wrote (34)11/13/1998 3:08:00 PM
From: Edward P. Buzinky  Read Replies (1) of 39
 
Hey, I do.

With the stock at .16, the biz is virtually valued at debt. They do have a great CA franchise; rev/center breaks records each month; expenses are down; oper profit is growing and biting into the debt service; buying back their debentures; signing new contracts; about to open a state-of-art Beverly Hills center which consolidates the 3 existing BH centers and which will save them 1 - 2MM/year, while adding another open MR to the site.

EBITDA for the 30 centers is huge (note that I didn't say for the company). 5 or 6 times that, then we're somewhere between .5 and 1 per share. It's a natural move for SCOR or IHSC - both have the bucks and could lock up the CA market. Use of imaging will do nothing but increase.

Too bad all the other former acquirors are in the toilet. But the retention of the investment bankers shows that someone else in the biz besides PMDX sees value here. They'll be rewarded if they bring the co a deal. Clearly they think they can, or they would not have bothered getting involved.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext